The Politics of the International Pricing of Prescription Drugs

Name: The Politics of the International Pricing of Prescription Drugs
Price: 140 AUD
Availability: OutOfStock
ISBN: 9780275980108

Christophe S. Harrison, Christophe S. Harrison

$140

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We will update you on expected arrival time to us. If this delay is too long, please let us know within 2 business days and we can give you options regarding cancelling or adjusting your order. More details on cancelling your order can be found in our Terms of Trade.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Praeger Publishers Inc
30 March 2004

Political economy; Pharmaceutical industries

Harrison analyzes how the U.S. research pharmaceutical industry, faced with domestic political opposition to the prices it charged for prescription drugs, chose to pursue its policy goal of greater appropriability of its intellectual property through the institutions of foreign economic policymaking.

As Harrison explains, a new body of literature has developed to analyze the emergence of intellectual property as a major international trade issue. For many researchers, the inclusion of trade related intellectual property (TRIPS) into the Uruguay round of the General Agreement on Tariffs and trade (GATT) negotiations marks an important demonstration of the political influence of U.S. knowledge-intensive industries. However, as he demonstrates, a more thorough specification of the domestic political environment reveals that the research pharmaceutical industry was incapable of achieving its domestic policy objectives at the same time that it is credited with immense international political power.

By providing a theory of institutional choice, Harrison reconciles this incongruity. He explains the strategic choices of the research pharmaceutical industry as a function of the transaction costs associated with pursuing its policy objectives within a variety of institutional alternatives. He concludes that he internationalization of intellectual property rights was a result of the changing domestic political environment in which the research pharmaceutical industry found itself the loser in a series of domestic economic policy battles. A thoughtful analysis of particular important to scholars, researchers, and policy makers involved with international trade, intellectual property, the pharmaceutical industry, and public policy.

By: Christophe S. Harrison, Christophe S. Harrison
Imprint: Praeger Publishers Inc
Country of Publication: United States
Dimensions: Height: 234mm, Width: 156mm, Spine: 14mm
Weight: 493g
ISBN: 9780275980108
ISBN 10: 0275980103
Pages: 224
Publication Date: 30 March 2004
Recommended Age: From 7 to 17 years
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

List of Tables List of Figures Introduction Theory Intellectual Property and Public Goods Domestic Politics: A History of the U.S. Research Pharmaceutical Industry Domestic Politics: A Domestic Solution to an International Problem International Politics: Bilateralism without Institutionalization International Politics: Bilateralism with Institutionalization International Politics: The Move Towards Multilateralism Conclusion Selected Bibliography

CHRISTOPHER SCOTT HARRISON is Associate in the Intellectual Property Section of the law firm Fulbright & Jaworski L.L.P. in Austin, Texas. Dr. Harrison received his Ph.D. in Political Science and his J.D. from the University of North Carolina. He has published articles on legal issues concerning the pharmaceuticals industry.